Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
Gynecologic Oncology|September 16, 2022
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors GroupSabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Cells|June 25, 2020
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic AnalysisAurélie Auguste, Félix Blanc-Durand, Marc Deloger, et al.
Gynecologic Oncology|July 30, 2020
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)Félix Blanc-Durand, Claudia Lefeuvre-Plesse, Isabelle Ray-Coquard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2023
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancersStephane Niyoteka, Romain-David Seban, Rahimeh Rouhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-LowDione van Dijk, Lisa Vermij, Alicia León-Castillo, et al.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2024
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological CorrelatesEzgi Dicle Serbes, Nanda Horeweg, Carlos Parra-Herran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2018
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativeAurélie Auguste, Catherine Genestie, Marco De Bruyn, et al.
Acta Neuropathologica Communications|May 7, 2026
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related featuresMartin Raby, Alexis Trécourt, Euphrasie Servant, et al.
Pageof 13